$988 Million is the total value of First Light Asset Management, LLC's 71 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 19.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Sell | PROTHENA CORPORATION PLC | $93,290,000 | +77.3% | 1,538,678 | -20.6% | 9.44% | +54.2% |
| MODN | Sell | MODEL N INC | $89,279,000 | +26.7% | 2,608,221 | -5.3% | 9.04% | +10.2% |
| ATRC | Buy | ATRICURE INC | $58,441,000 | -3.3% | 1,494,655 | +1.0% | 5.91% | -15.9% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $40,144,000 | +1.1% | 7,067,572 | +0.5% | 4.06% | -12.1% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $37,409,000 | +135.1% | 166,316 | +32.2% | 3.79% | +104.4% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $36,861,000 | -11.0% | 932,244 | -1.0% | 3.73% | -22.6% |
| SIBN | Buy | SI-BONE INC | $35,408,000 | +33.7% | 2,027,963 | +1.1% | 3.58% | +16.3% |
| CUTR | Sell | CUTERA INC | $34,801,000 | +20.2% | 763,180 | -1.1% | 3.52% | +4.6% |
| AXGN | Sell | AXOGEN INC | $34,709,000 | +40.1% | 2,911,824 | -3.7% | 3.51% | +21.9% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $34,331,000 | -12.2% | 492,555 | -17.3% | 3.47% | -23.7% |
| OMCL | Buy | OMNICELL INC | $30,383,000 | -23.0% | 349,106 | +0.6% | 3.08% | -33.1% |
| RETA | New | REATA PHARMACEUTICALS INC | $26,512,000 | – | 1,054,985 | +100.0% | 2.68% | – |
| CRNX | Buy | CRINETICS PHARMACEUTICALS INC | $26,448,000 | +14.3% | 1,346,652 | +8.5% | 2.68% | -0.6% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $25,999,000 | +35.9% | 2,974,658 | +1.7% | 2.63% | +18.2% |
| BLU | Sell | BELLUS HEALTH INC | $25,152,000 | +13.0% | 2,381,857 | -1.1% | 2.54% | -1.7% |
| NEO | Buy | NEOGENOMICS INC | $23,420,000 | +5.8% | 2,720,099 | +0.2% | 2.37% | -8.0% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $23,237,000 | -16.0% | 485,620 | +3.9% | 2.35% | -27.0% |
| KROS | Sell | KEROS THERAPEUTICS INC | $22,505,000 | +36.1% | 598,213 | -0.0% | 2.28% | +18.4% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOGIES | $22,316,000 | +25.4% | 316,809 | +0.9% | 2.26% | +9.0% |
| Buy | PARAGON 28 INC | $22,062,000 | +12.3% | 1,238,055 | +0.0% | 2.23% | -2.3% | |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $20,161,000 | +227.1% | 965,114 | +25.4% | 2.04% | +184.5% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $18,792,000 | -30.4% | 453,794 | +0.3% | 1.90% | -39.4% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLC | $16,392,000 | +38.7% | 704,721 | +0.1% | 1.66% | +20.7% |
| INSM | Sell | INSMED INC | $16,293,000 | +8.4% | 756,417 | -0.8% | 1.65% | -5.7% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $14,245,000 | +4.9% | 308,728 | -1.9% | 1.44% | -8.7% |
| KRMD | Buy | KORU MEDICAL SYSTEMS INC | $13,991,000 | -9.4% | 6,273,773 | +2.8% | 1.42% | -21.2% |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $12,498,000 | -14.2% | 955,505 | -15.9% | 1.26% | -25.3% |
| HCAT | Buy | HEALTH CATALYST INC | $11,153,000 | -32.2% | 1,149,833 | +1.3% | 1.13% | -41.0% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $10,985,000 | +103.3% | 522,864 | +88.3% | 1.11% | +76.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $10,454,000 | +20.4% | 123,322 | +17.7% | 1.06% | +4.6% |
| BVS | Buy | BIOVENTUS INC | $9,792,000 | +6.5% | 1,398,922 | +3.7% | 0.99% | -7.4% |
| CDNA | Sell | CAREDX INC | $9,358,000 | -43.9% | 549,797 | -29.2% | 0.95% | -51.2% |
| PFMT | Buy | PERFORMANT FINANCIAL CORPORATION | $9,287,000 | -29.7% | 5,020,107 | +0.0% | 0.94% | -38.8% |
| Buy | MAXCYTE INC | $8,857,000 | +41.9% | 1,362,543 | +3.3% | 0.90% | +23.4% | |
| PFE | Buy | PFIZER INC | $6,439,000 | -16.1% | 147,151 | +0.5% | 0.65% | -27.0% |
| AKUMIN INC | $6,437,000 | +185.2% | 3,764,264 | 0.0% | 0.65% | +147.5% | ||
| TMDX | New | TRANSMEDICS GROUP INC | $6,418,000 | – | 153,769 | +100.0% | 0.65% | – |
| LABU | New | DIREXION DAILY S&P BIOTECH BULL 3X SHARES | $6,013,000 | – | 857,815 | +100.0% | 0.61% | – |
| ABCM | Buy | ABCAM PLC | $5,750,000 | +80.1% | 383,557 | +73.7% | 0.58% | +56.5% |
| OPRX | Buy | OPTIMIZERX CORP | $5,395,000 | -45.4% | 364,036 | +0.9% | 0.55% | -52.5% |
| GMAB | Buy | GENMAB AS | $5,196,000 | -0.6% | 161,727 | +0.5% | 0.53% | -13.5% |
| CSTL | New | CASTLE BIOSCIENCES INC | $4,257,000 | – | 163,224 | +100.0% | 0.43% | – |
| NARI | Buy | INARI MEDICAL INC. | $3,292,000 | +7.5% | 45,313 | +0.6% | 0.33% | -6.5% |
| MIRO | MIROMATRIX MEDICAL INC | $2,260,000 | +9.8% | 516,007 | 0.0% | 0.23% | -4.6% | |
| SLP | Sell | SIMULATIONS PLUS INC | $1,750,000 | -53.3% | 36,061 | -52.5% | 0.18% | -59.4% |
| ANTM | ELEVANCE HEALTH INC | $565,000 | -5.8% | 1,244 | 0.0% | 0.06% | -18.6% | |
| CI | CIGNA CORPORATION | $539,000 | +5.3% | 1,943 | 0.0% | 0.06% | -8.3% | |
| CVS | CVS HEALTH CORPORATION | $526,000 | +2.9% | 5,519 | 0.0% | 0.05% | -10.2% | |
| BMY | BRISTOL-MYERS SQUIBB CO | $516,000 | -7.7% | 7,256 | 0.0% | 0.05% | -20.0% | |
| HUM | HUMANA INC | $518,000 | +3.6% | 1,068 | 0.0% | 0.05% | -10.3% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $516,000 | -11.2% | 2,466 | 0.0% | 0.05% | -23.5% | |
| ABBV | ABBVIE | $502,000 | -12.4% | 3,740 | 0.0% | 0.05% | -23.9% | |
| MCK | MCKESSON CORP | $457,000 | +4.1% | 1,346 | 0.0% | 0.05% | -9.8% | |
| BDX | BECTON DICKINSON AND CO | $421,000 | -9.5% | 1,888 | 0.0% | 0.04% | -20.4% | |
| WAT | WATERS CORPORATION | $414,000 | -18.5% | 1,536 | 0.0% | 0.04% | -28.8% | |
| GILD | GILEAD SCIENCES INC | $414,000 | 0.0% | 6,705 | 0.0% | 0.04% | -12.5% | |
| NVST | ENVISTA HOLDINGS CORP | $387,000 | -14.9% | 11,793 | 0.0% | 0.04% | -26.4% | |
| HOLX | HOLOGIC INC | $377,000 | -6.9% | 5,845 | 0.0% | 0.04% | -19.1% | |
| ITGR | INTEGER HOLDINGS CORPORATION | $364,000 | -11.9% | 5,846 | 0.0% | 0.04% | -22.9% | |
| JNJ | JOHNSON & JOHNSON | $353,000 | -8.1% | 2,161 | 0.0% | 0.04% | -20.0% | |
| PRGO | PERRIGO COMPANY | $350,000 | -12.3% | 9,823 | 0.0% | 0.04% | -23.9% | |
| NUVA | NUVASIVE INC | $344,000 | -10.9% | 7,850 | 0.0% | 0.04% | -22.2% | |
| TAK | TAKEDA PHARMACEUTICAL CO | $332,000 | -7.8% | 25,630 | 0.0% | 0.03% | -19.0% | |
| BAX | BAXTER INTERNATIONAL INC | $319,000 | -16.3% | 5,929 | 0.0% | 0.03% | -27.3% | |
| ICUI | ICU MEDICAL INC | $307,000 | -8.4% | 2,039 | 0.0% | 0.03% | -20.5% | |
| New | GLAXOSMITHKLINE PLC | $296,000 | – | 10,058 | +100.0% | 0.03% | – | |
| AVTR | AVANTOR INC | $286,000 | -37.0% | 14,596 | 0.0% | 0.03% | -45.3% | |
| SYNH | SYNEOS HEALTH INC CLASS A | $270,000 | -34.3% | 5,736 | 0.0% | 0.03% | -43.8% | |
| SNY | SANOFI-SYNTHELABO | $253,000 | -24.0% | 6,650 | 0.0% | 0.03% | -33.3% | |
| New | SONENDO INC | $239,000 | – | 223,393 | +100.0% | 0.02% | – | |
| New | HALEON PLC | $77,000 | – | 12,574 | +100.0% | 0.01% | – | |
| UHS | Exit | UNIVERSAL HEALTH SERVICES INC CLASS B | $0 | – | -2,050 | -100.0% | -0.02% | – |
| GSK | Exit | GLAXOSMITHKLINE PLC | $0 | – | -12,574 | -100.0% | -0.06% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -1,431,387 | -100.0% | -0.14% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -15,392 | -100.0% | -0.28% | – |
| IWO | Exit | ISHARES RUSSELL 2000 GROWTH ETF | $0 | – | -13,242 | -100.0% | -0.32% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -685,213 | -100.0% | -0.83% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS | $0 | – | -140,801 | -100.0% | -1.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.